FactSet Releases Transcript Assistant, A Game-Changing AI Tool for Earnings Call Analysis
12 mars 2024 07h00 HE
|
FactSet Research Systems Inc.
NORWALK, Conn., March 12, 2024 (GLOBE NEWSWIRE) -- FactSet, a global financial digital platform and enterprise solutions provider, today announced the release of Transcript Assistant, a...
Broadwind Announces Fourth Quarter and Full-Year 2023 Results
05 mars 2024 07h00 HE
|
Broadwind, Inc.
CICERO, Ill., March 05, 2024 (GLOBE NEWSWIRE) -- Broadwind (Nasdaq: BWEN, or the “Company”), a diversified precision manufacturer of specialized components and solutions serving global markets,...
Visteon Announces 2023 Financial Results and 2024 Outlook
20 févr. 2024 06h55 HE
|
Visteon Corporation
VAN BUREN TOWNSHIP, Mich., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Visteon Corporation (NASDAQ: VC) today reported fourth quarter and full-year 2023 financial results. Highlights include: $990 million...
ARCA biopharma Announces 2023 Financial Results
01 févr. 2024 16h35 HE
|
ARCA biopharma, Inc.
ARCA biopharma Announces 2023 Financial Results
Visteon to Announce Fourth Quarter and Full-Year 2023 Results on Feb. 20
31 janv. 2024 16h15 HE
|
Visteon Corporation
VAN BUREN TOWNSHIP, Mich., Jan. 31, 2024 (GLOBE NEWSWIRE) -- Visteon Corporation (Nasdaq: VC), a global technology company serving the mobility industry, will release its fourth quarter and...
Five Star Bancorp Announces Quarterly and Annual Results
29 janv. 2024 18h00 HE
|
Five Star Bank
RANCHO CORDOVA, Calif., Jan. 29, 2024 (GLOBE NEWSWIRE) -- Five Star Bancorp (Nasdaq: FSBC) (the “Company” or “Five Star”), the holding company for Five Star Bank, today reported net income of $10.8...
Capital Bancorp, Inc. Reports Fourth Quarter 2023 Net Income of $9.0 million, or $0.65 per share
22 janv. 2024 16h10 HE
|
Capital Bancorp, Inc.
Diluted EPS of $0.65, ROAA of 1.63%, and ROAE of 14.44% for 4Q 2023Tangible Book Value Per Share(1) of $18.31 for 4Q 2023 up 15.6% from 4Q 2022Loan Growth of $40.7 million, or 8.7% annualized for 4Q...
Alvotech Reports Financial Results for First Nine Months of 2023 and Provides a Business Update
28 nov. 2023 16h15 HE
|
Alvotech
Product revenue for the nine months of 2023 increased to $29.8 million, compared to $11.1 million for the same period in 2022Marketing authorization was received for AVT04 in Canada and Japan, the...
Alvotech to Report Financial Results for the First Nine Months of 2023 on November 28, 2023, and Host Business Update Conference Call on November 29, 2023, at 8:00 am ET
21 nov. 2023 08h00 HE
|
Alvotech
REYKJAVIK, ICELAND, Nov. 21, 2023 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specialized in the development and manufacture of biosimilar medicines for patients worldwide,...
Beam Global Announces Third Quarter 2023 Results
14 nov. 2023 07h05 HE
|
Beam Global
Beam Global announces Q3 2023 Results